[
  {
    "ts": null,
    "headline": "The beginning of the end: Eliquis sales forecast to plummet as EU patent expiry nears",
    "summary": "The BMS-Pfizer alliance has dominated the anticoagulant drug market, earning approximately $82.6bn in revenue since 2011.",
    "url": "https://finnhub.io/api/news?id=b8f56076e94d31e105791c98b9b1fa8643e7517866008137342159322c976aca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769615340,
      "headline": "The beginning of the end: Eliquis sales forecast to plummet as EU patent expiry nears",
      "id": 138285224,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The BMS-Pfizer alliance has dominated the anticoagulant drug market, earning approximately $82.6bn in revenue since 2011.",
      "url": "https://finnhub.io/api/news?id=b8f56076e94d31e105791c98b9b1fa8643e7517866008137342159322c976aca"
    }
  },
  {
    "ts": null,
    "headline": "Some of Pharma's Biggest Brands Face a New Reality",
    "summary": "A government process quietly moves forward",
    "url": "https://finnhub.io/api/news?id=48ae2d909b1bce31a2977fa3cc46c5767b5b75f264a8467010fbce54b699fc3f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769611689,
      "headline": "Some of Pharma's Biggest Brands Face a New Reality",
      "id": 138281443,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "A government process quietly moves forward",
      "url": "https://finnhub.io/api/news?id=48ae2d909b1bce31a2977fa3cc46c5767b5b75f264a8467010fbce54b699fc3f"
    }
  },
  {
    "ts": null,
    "headline": "Healthy Returns: Botox, Trulicity among 15 drugs added to Medicare price negotiations",
    "summary": "The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay a historic settlement.",
    "url": "https://finnhub.io/api/news?id=5ae77557973ed9453fe5371e6a9ab2b8b579680df212327413d4e8b25d81b98e",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769602052,
      "headline": "Healthy Returns: Botox, Trulicity among 15 drugs added to Medicare price negotiations",
      "id": 138282758,
      "image": "https://image.cnbcfm.com/api/v1/image/107188275-16753645842023-02-02t183236z_737430976_rc253z9n9jw3_rtrmadp_0_lilly-results.jpeg?v=1694350801&w=1920&h=1080",
      "related": "BMY",
      "source": "CNBC",
      "summary": "The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay a historic settlement. ",
      "url": "https://finnhub.io/api/news?id=5ae77557973ed9453fe5371e6a9ab2b8b579680df212327413d4e8b25d81b98e"
    }
  },
  {
    "ts": null,
    "headline": "Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested three years ago",
    "summary": "It is doubtless a positive to see that the Bristol-Myers Squibb Company ( NYSE:BMY ) share price has gained some 30% in...",
    "url": "https://finnhub.io/api/news?id=c098ce0144c058de93d554b420721d94f8041a286042a63257a49dba423d766b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769601616,
      "headline": "Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested three years ago",
      "id": 138280750,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "It is doubtless a positive to see that the Bristol-Myers Squibb Company ( NYSE:BMY ) share price has gained some 30% in...",
      "url": "https://finnhub.io/api/news?id=c098ce0144c058de93d554b420721d94f8041a286042a63257a49dba423d766b"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Stock Outlook: Is Wall Street Bullish or Bearish?",
    "summary": "Bristol-Myers Squibb has lagged the broader market over the past year, but analysts are growing optimistic about the company’s outlook.",
    "url": "https://finnhub.io/api/news?id=80b3a68d87ab467e550c0917b870fc151a2f6ab486651c9ad19f2662c0ad540b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769595676,
      "headline": "Bristol-Myers Squibb Stock Outlook: Is Wall Street Bullish or Bearish?",
      "id": 138280751,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Bristol-Myers Squibb has lagged the broader market over the past year, but analysts are growing optimistic about the company’s outlook.",
      "url": "https://finnhub.io/api/news?id=80b3a68d87ab467e550c0917b870fc151a2f6ab486651c9ad19f2662c0ad540b"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer's top 10 things to watch in the stock market Wednesdsay",
    "summary": "The S&P 500 and Nasdaq were set to open higher this morning, driven by soaring chip stocks.",
    "url": "https://finnhub.io/api/news?id=c67746c4498bd8d5d5c9348e0f7b921a2551f6d0d51c01da10ee6d7540a9e045",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769589885,
      "headline": "Jim Cramer's top 10 things to watch in the stock market Wednesdsay",
      "id": 138282415,
      "image": "https://image.cnbcfm.com/api/v1/image/108217759-1761656513846-gettyimages-2235448475-META_CONNECT.jpeg?v=1767967698&w=1920&h=1080",
      "related": "BMY",
      "source": "CNBC",
      "summary": "The S&P 500 and Nasdaq were set to open higher this morning, driven by soaring chip stocks.",
      "url": "https://finnhub.io/api/news?id=c67746c4498bd8d5d5c9348e0f7b921a2551f6d0d51c01da10ee6d7540a9e045"
    }
  }
]